Immunitybio Inc (IBRX) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Immunitybio inc   (NASDAQ: IBRX)
 

Immunitybio Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Immunitybio Inc inventory turnover ratio, the Immunitybio Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 0.43 in the second quarter 2026, a new company high. Average inventory processing period, for the Immunitybio Inc in Jun 30 2026 quarter, has decreased to 849 days, compare to 1460 days, in the Mar 31 2026 quarter.

Within Healthcare sector 355 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1548 in the first quarter 2026, to 1942.

IBRX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Immunitybio Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IBRX Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -70.78 % -93.52 % -89 % 242.34 % 266.65 %
Y / Y Cost of Sales Growth 119.12 % 310.34 % - - -
Inventory Turnover Ratio (TTM) 0.43 0.25 0.13 0.05 0.03
IBRX's Total Ranking # 1942 # 1548 # 1516 # 1218 # 1570
Average inventory processing period 842 1447 2750 7393 11907
Seq. Inventory Growth 254.66 % -39.89 % -86.42 % 0.95 % -21.36 %
Seq. Cost of Sales Growth 25.21 % -37.7 % 115.82 % 30.15 % 134.48 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 26
Healthcare Sector # 356
Overall Market # 1942

Inventory Turnover Ratio Statistics
High Average Low
0.43 0.15 0.01
(Jun 30 2026)   (Mar 31 2025)



IBRX Company Profile >> Back to IBRX Efficiency Comparisons >> Compare IBRX Inventory Turnover Ratio to its Competitors

Financial Statements
Immunitybio Inc 's Inventories $ 2 Millions Visit IBRX's Balance sheet
Immunitybio Inc 's Cost of Revenues TTM $ 1 Millions Visit IBRX's Income Statement
What are IBRX's Sales? Visit IBRX's Sales by Segment

Other Inventory Turnover Ratios
Immunitybio Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IBRX's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IBRX's Competitors
Inventory Turnover Ratio for IBRX's Suppliers
Inventory Turnover Ratio for IBRX's Customers

You may also want to know
IBRX's Sales Growth Rates IBRX's Pe Price to earnings ratio IBRX's Receivables Turnover Ratio IBRX's Stock Quote
IBRX's Net Income Growth Rates IBRX's Ps Price to Sales ratio IBRX's Sales per Employee IBRX's Asset Turnover Ratio
IBRX's Net Margin IBRX's Pb Price to Book ratio IBRX's Financial Strength Ratios IBRX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Urogen Pharma Ltd   1.54 $ 17.278  Millions$ 11  Millions
Bausch and Lomb Corp  1.54 $ 1,523.000  Millions$ 989  Millions
Staar Surgical Co  1.53 $ 79.388  Millions$ 52  Millions
Abeona Therapeutics Inc   1.51 $ 8.405  Millions$ 6  Millions
Enovis Corp  1.50 $ 898.682  Millions$ 601  Millions
Axogen inc   1.45 $ 63.909  Millions$ 44  Millions
Cv Sciences Inc   1.45 $ 5.804  Millions$ 4  Millions
Nuwellis Inc   1.43 $ 2.732  Millions$ 2  Millions
Mannkind Corporation  1.43 $ 55.824  Millions$ 39  Millions
Insmed Inc  1.43 $ 188.217  Millions$ 132  Millions
Teleflex Incorporated  1.42 $ 689.171  Millions$ 485  Millions
Cormedix Inc   1.42 $ 45.432  Millions$ 32  Millions
Sight Sciences Inc   1.41 $ 10.014  Millions$ 7  Millions
Outset Medical Inc   1.40 $ 67.951  Millions$ 48  Millions
Biocorrx Inc   1.40 $ 0.170  Millions$ 0  Millions
Lensar Inc   1.38 $ 31.126  Millions$ 23  Millions
Arcutis Biotherapeutics Inc   1.35 $ 41.096  Millions$ 30  Millions
Alphatec Holdings Inc   1.32 $ 237.415  Millions$ 179  Millions
Cerus Corporation  1.32 $ 78.000  Millions$ 59  Millions
Elanco Animal Health Incorporated  1.29 $ 2,241.000  Millions$ 1,733  Millions
Xtant Medical Holdings Inc   1.28 $ 43.701  Millions$ 34  Millions
Edwards Lifesciences Corporation  1.28 $ 1,443.400  Millions$ 1,129  Millions
Globus Medical Inc   1.27 $ 989.145  Millions$ 779  Millions
Karyopharm Therapeutics Inc   1.27 $ 4.942  Millions$ 4  Millions
Clene Inc   1.25 $ 0.059  Millions$ 0  Millions
Si bone inc   1.24 $ 44.462  Millions$ 36  Millions
Kyntra Bio Inc   1.24 $ 4.444  Millions$ 4  Millions
Astrotech Corp  1.24 $ 0.696  Millions$ 1  Millions
Pulmonx Corporation  1.24 $ 20.014  Millions$ 16  Millions
Biolife Solutions Inc   1.24 $ 39.035  Millions$ 32  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.